HPTN Publications
Looking to submit your manuscript for review?
Your manuscript can be reviewed by our Manuscript Review committee. Get the submission form.
Filter publications by:
Anderson PL, Marzinke MA, Glidden DV . Updating the adherence-response for oral F-TDF for PrEP among cisgender women. Clin Infect Dis.
2023
Clin Infect Dis
HPTN 084
Aroke H, Buchanan A, Katenka N, Crawford FW, Lee T, Halloran ME, Latkin C . Evaluating the Mediating Role of Recall of Intervention Knowledge in the Relationship Between a Peer-Driven Intervention and HIV Risk Behaviors Among People Who Inject Drugs. AIDS Behav. 2023, 27: 578-590
2023
AIDS Behav
HPTN 037
Avery LB, Sacktor N, McArthur JC, Hendrix CW . Protein-free efavirenz concentrations in cerebrospinal fluid & blood plasma are equivalent: Applying the law of mass action to predict protein-free drug concentration. Antimicrob Agents Chemother. 2013, 57: 1409-14
2013
Antimicrob Agents Chemother
Baeten JM, Haberer JE, Liu AY, Sista N . Preexposure prophylaxis for HIV prevention: where have we been and where are we going?. J Acquir Immune Defic Syndr. 2013, 63: S122-9
2013
J Acquir Immune Defic Syndr
Bauman LJ, Mellins CA, Klitzman R . Whether to Waive Parental Permission in HIV Prevention Research Among Adolescents: Ethical and Legal Considerations [HPTN 078]. J Law Med Ethics. 2020, 48: 188-201
2020
J Law Med Ethics
HPTN 078
Beauchamp G, Hosek S, Donnell D, Chan KCG, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C; HPTN 082 study team . The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082. AIDS Behav. 2024, 5: 1512-1521
2024
AIDS Behav
HPTN 082
Bekker LG, Roux S, Sebastien E, Yola N, Amico KR, Hughes JP, Marzinke MA, Hendrix CW, Anderson PL, Elharrar V, Stirratt M, Piwowar-Manning E, Eshleman SH, McKinstry L, Li M, Dye BJ, Grant RM, for the HPTN 067/ADAPT Cape Town study team . Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. Lancet. 2018, 5: e68-e78
2018
Lancet
HPTN 067
Bell-Mandla NF, Sloot R, Maarman G, Griffith S, Moore A, Floyd S, Hayes R, Fidler S, Ayles H, Bock P . Improving retention of community-recruited participants in HIV prevention research through Saturday household visits; findings from the HPTN 071 (PopART) study in South Africa. BMC Med Res Methodol. 2021, 21: 242
2021
BMC Med Res Methodol
HPTN 071